Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel

A case control study, which has been peer reviewed and published in the New England Journal of Medicine, compared 596 618 people who were newly vaccinated in Israel and matched them to unvaccinated controls.1 Two doses of the mRNA vaccine reduced symptomatic cases by 94%, hospitalisation by 87%, and severe covid-19 by 92%, according to the data from the Clalit Institute for Research which is Israel’s biggest healthcare provider. Read the full article here.

E-mail me when people leave their comments –

You need to be a member of ikann to add comments!

Join ikann